Journal articles on the topic 'Addictovigilance'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Addictovigilance.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Jouanjus, Emilie, Joëlle Micallef, Michel Mallaret, and Maryse Lapeyre-Mestre. "Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions." International Journal of Neuropsychopharmacology 22, no. 8 (2019): 528–30. http://dx.doi.org/10.1093/ijnp/pyz033.
Full textChavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul, and Danièle Debruyne. "New Synthetic Drugs in Addictovigilance." Therapies 70, no. 2 (2015): 179–89. http://dx.doi.org/10.2515/therapie/2015001.
Full textChavant, François, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul, and Danièle Debruyne. "Nouvelles drogues de synthèse en addictovigilance." Therapies 70, no. 2 (2015): 167–78. http://dx.doi.org/10.2515/therapie/2014235.
Full textJouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu, and Amélie Daveluy. "Comment identifier un signal en addictovigilance ?" Therapies 70, no. 2 (2015): 113–22. http://dx.doi.org/10.2515/therapie/2015009.
Full textDaveluy, Amélie, Joëlle Perri-Plandé, Marie Baumevieille, Alexandre Peyré, and Ghada Miremont-Salamé. "Addictovigilance dans les départements d’Outre-Mer." Therapies 73, no. 6 (2018): 565. http://dx.doi.org/10.1016/j.therap.2018.09.062.
Full textGibaja, Valérie, Audrey Fresse, Juliana Tournebize, and Maryse Lapeyre Mestre. "Poudre d’opium et addictovigilance : état des lieux." Therapies 76, no. 2 (2021): 164. http://dx.doi.org/10.1016/j.therap.2021.01.015.
Full textGentile, Gaétan, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus, and Joëlle Micallef. "Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?" Fundamental & Clinical Pharmacology 32, no. 6 (2018): 643–51. http://dx.doi.org/10.1111/fcp.12401.
Full textLapeyre-Mestre, Maryse. "Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?" Fundamental & Clinical Pharmacology 32, no. 6 (2018): 641–42. http://dx.doi.org/10.1111/fcp.12425.
Full textJouanjus, Emilie, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu, and Amélie Daveluy. "Signal Identification in Addictovigilance: the Functioning of the French System." Therapies 70, no. 2 (2015): 123–31. http://dx.doi.org/10.2515/therapie/2015011.
Full textBatisse, A., C. Eiden, R. Le Boisselier, et al. "New psychoactive substances: French addictovigilance data between 2009 and 2017." Toxicologie Analytique et Clinique 31, no. 2 (2019): S42—S43. http://dx.doi.org/10.1016/j.toxac.2019.03.057.
Full textLapeyre-Mestre, Maryse, Alexandra Boucher, Amélie Daveluy, et al. "Addictovigilance contribution during COVID-19 epidemic and lockdown in France." Therapies 75, no. 4 (2020): 343–54. http://dx.doi.org/10.1016/j.therap.2020.06.006.
Full textMarillier, M., A. Batisse, C. Chevallier, and S. Djezzar. "Behavioral disorders and new psychoactive substances abuse, a French case series." European Psychiatry 33, S1 (2016): S307. http://dx.doi.org/10.1016/j.eurpsy.2016.01.1050.
Full textEiden, Céline, Sarah Leone-Burgos, Anaïs Serre, et al. "Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network." Fundamental & Clinical Pharmacology 32, no. 6 (2018): 654–62. http://dx.doi.org/10.1111/fcp.12395.
Full textRousselet, Morgane, Fanny Feuillet, Marie Gerardin, Pascale Jolliet, Jean-Benoit Hardouin, and Caroline Victorri-Vigneau. "The French addictovigilance network clinical assessment: Z-drugs, true false twins." Expert Opinion on Drug Safety 16, no. 9 (2017): 1063–69. http://dx.doi.org/10.1080/14740338.2017.1346084.
Full textLapeyre-Mestre, Maryse, and Mathilde Dupui. "Système de surveillance en addictovigilance : quelles données pharmacoépidémiologiques à l'échelle de l'Europe ?" Therapies 70, no. 2 (2015): 147–56. http://dx.doi.org/10.2515/therapie/2015006.
Full textMicallef, Joëlle, Elisabeth Frauger, Aurore Palmaro, Quentin Boucherie, and Maryse Lapeyre Mestre. "Un exemple d’investigation d’un phénomène « émergent » en addictovigilance : à propos du méthylphénidate." Therapies 70, no. 2 (2015): 191–96. http://dx.doi.org/10.2515/therapie/2015012.
Full textVictorri-Vigneau, Caroline, Jean Benoit Hardouin, Morgane Rousselet, et al. "Multicentre study for validation of the French addictovigilance network reports assessment tool." British Journal of Clinical Pharmacology 82, no. 4 (2016): 1030–39. http://dx.doi.org/10.1111/bcp.13044.
Full textBatisse, Anne, Juliana Tournebize, Julie Heredia, Leila Chaouachi, Samira Djezzar, and Le Boisselier Reynald. "AddictoVigilance sur le mode de consommation par vapotage de substances psychoactives illicites." Toxicologie Analytique et Clinique 32, no. 4 (2020): S18—S19. http://dx.doi.org/10.1016/j.toxac.2020.09.043.
Full textMicallef, Joëlle, and Michel Mallaret. "Les 25 ans des centres d’évaluation et d’information sur la pharmacodépendance-addictovigilance." Therapies 71, no. 4 (2016): 375–78. http://dx.doi.org/10.1016/j.therap.2016.05.001.
Full textMicallef, Joëlle, and Maryse Lapeyre-Mestre. "Addictovigilance : le défi pharmacologique de l’évaluation et de la prévention des substances à risque." Therapies 70, no. 2 (2015): 111. http://dx.doi.org/10.2515/therapie/2015017.
Full textRoussin, Anne, Odile Doazan d’Ouince, Hélène Géniaux, and Clémence Halberer. "Un exemple d’évaluation de l’abus et de la dépendance en addictovigilance : à propos du tramadol." Therapies 70, no. 2 (2015): 203–11. http://dx.doi.org/10.2515/therapie/2014221.
Full textMicallef, J. "Nouveaux produits de synthèse (NPS) et addictovigilance : de la pharmacodynamie théorique aux complications somatiques réelles." Toxicologie Analytique et Clinique 30, no. 2 (2018): S44—S45. http://dx.doi.org/10.1016/j.toxac.2018.04.053.
Full textVodovar, Dominique, and Bruno Megarbane. "Ephenidine, diphenidine and methoxphenidine complications reported to the French Addictovigilance Network: another brick in the wall!" Fundamental & Clinical Pharmacology 32, no. 6 (2018): 652–53. http://dx.doi.org/10.1111/fcp.12407.
Full textDupui, Mathilde, Joëlle Micallef, and Maryse Lapeyre-Mestre. "Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution." Therapies 74, no. 2 (2019): 307–14. http://dx.doi.org/10.1016/j.therap.2018.09.078.
Full textSchreck, Benoît, Nicolas Wagneur, Pascal Caillet, et al. "Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network." Drug and Alcohol Dependence 182 (January 2018): 27–32. http://dx.doi.org/10.1016/j.drugalcdep.2017.09.038.
Full textMicallef, Joëlle, and Michel Mallaret. "Assessment of new psychoactive substances: Opportunities for more interactions between analytical toxicologists and the French Addictovigilance Network." Toxicologie Analytique et Clinique 31, no. 4 (2019): 195–96. http://dx.doi.org/10.1016/j.toxac.2019.07.003.
Full textPeyrière, Hélène, Céline Eiden, Michel Mallaret, and Caroline Victorri-Vigneau. "Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres." Therapies 71, no. 6 (2016): 563–73. http://dx.doi.org/10.1016/j.therap.2016.07.001.
Full textGérardin, Marie, François Etcheverrigaray, Julien Nizard, et al. "Patients douloureux chroniques suivis dans un centre d’évaluation et de traitement de la douleur : quelles notifications en addictovigilance ?" Therapies 72, no. 1 (2017): 169. http://dx.doi.org/10.1016/j.therap.2016.11.052.
Full textMezaache, Salim, Franck Turlure, Nathalie Fredon, Joëlle Micallef, and Elisabeth Frauger. "Prévention des surdoses d’opioïdes et diffusion de naloxone : implication d’un CEIP-addictovigilance et illustration avec le projet POP." Therapies 77, no. 6 (2022): 761. http://dx.doi.org/10.1016/j.therap.2022.10.017.
Full textDaveluy, Amélie, Magali Labadie, Karine Titier, et al. "Poisoning by synthetic cathinones: Consumption behaviour and clinical description from 11 cases recorded by the Addictovigilance Centre of Bordeaux." Toxicologie Analytique et Clinique 29, no. 1 (2017): 34–40. http://dx.doi.org/10.1016/j.toxac.2016.11.005.
Full textDjezzar, S., F. Vorspan, D. Chataigner, E. Burin, R. Garnier, and J. P. Lépine. "Mephenesin dependence: A case series." European Psychiatry 26, S2 (2011): 29. http://dx.doi.org/10.1016/s0924-9338(11)71740-0.
Full textPonté, Camille. "Diagnostic de syndrome malin des neuroleptiques en contexte de consommation de substances dopaminergiques et sérotoninergiques ? Apport des données toxicologiques en Addictovigilance." Toxicologie Analytique et Clinique 32, no. 4 (2020): S51—S52. http://dx.doi.org/10.1016/j.toxac.2020.09.025.
Full textLe Boisselier, Reynald, Virginie Philippe, Céline Eiden, and Veronique Savignat. "Addictovigilance de la MDMA (ecstasy) en France : l’émergence de « nouvelles substances » ne doit pas éclipser le suivi sanitaire des plus anciennes." Therapies 77, no. 6 (2022): 757. http://dx.doi.org/10.1016/j.therap.2022.10.011.
Full textMarillier, M., A. Batisse, C. Chevallier, L. Laviale, and S. Djezzar. "Cannabinoid hyperemesis syndrome: A Parisian case series." European Psychiatry 41, S1 (2017): s869—s870. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1745.
Full textBatisse, A., N. Taright, C. Chevallier, M. Marillier, and S. Djezzar. "“Dual disorder with drugs”: Comparison of two French databases." European Psychiatry 33, S1 (2016): S72. http://dx.doi.org/10.1016/j.eurpsy.2016.01.005.
Full textBarrangou-Poueys-Darlas, Malcolm, Marie Gerardin, Sylvie Deheul, et al. "Poppers Use and High Methaemoglobinaemia: ‘Dangerous Liaisons’." Pharmaceuticals 14, no. 10 (2021): 1061. http://dx.doi.org/10.3390/ph14101061.
Full textBatisse, A., C. Chevallier, J. Azevedo Correia, et al. "Example of alert and reporting system of scopolamine poisoning among Parisian cocaine users at regional, national and European levels." European Psychiatry 41, S1 (2017): s858. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1709.
Full textGérardin, Marie, Morgane Rousselet, Pascal Caillet, et al. "French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol." BMJ Open 9, no. 6 (2019): e027443. http://dx.doi.org/10.1136/bmjopen-2018-027443.
Full textLapeyre-Mestre, Maryse. "Addictovigilance in women, the hidden part of the iceberg?" Therapies, October 2022. http://dx.doi.org/10.1016/j.therap.2022.10.006.
Full textBatisse, Anne, Céline Eiden, Sylvie Deheul, Emilie Monzon, Samira Djezzar, and Hélène Peyrière. "Chemsex practice in France: An update in Addictovigilance data." Fundamental & Clinical Pharmacology, September 14, 2021. http://dx.doi.org/10.1111/fcp.12725.
Full textGuerlais, Marylène, Aurélie Aquizerate, Arthur Lionnet, et al. "Nitrous oxide: a unique official French addictovigilance national survey." Frontiers in Public Health 11 (May 3, 2023). http://dx.doi.org/10.3389/fpubh.2023.1167746.
Full textTambon, Marine, Camille Ponté, Emilie Jouanjus, Nathalie Fouilhé, Joelle Micallef, and Maryse Lapeyre-Mestre. "Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance." Frontiers in Psychiatry 12 (February 3, 2021). http://dx.doi.org/10.3389/fpsyt.2021.639780.
Full text"Erratum: Nitrous oxide: a unique official French addictovigilance national survey." Frontiers in Public Health 11 (July 4, 2023). http://dx.doi.org/10.3389/fpubh.2023.1235720.
Full textAquizerate, Aurélie, Edouard-Jules Laforgue, Marion Istvan, et al. "Evolution of the Addictovigilance Signal of Zopiclone: A 2014–2020 National Follow-up Study." International Journal of Mental Health and Addiction, May 31, 2023. http://dx.doi.org/10.1007/s11469-023-01078-y.
Full textDiaz, Laurine, Céline Eiden, Emilie Jouanjus, et al. "Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020." Therapies, February 2023. http://dx.doi.org/10.1016/j.therap.2023.02.002.
Full textEiden, Céline, Marc Vincent, Chris Serrand, et al. "Health consequences of cocaine use in France: data from the French Addictovigilance Network." Fundamental & Clinical Pharmacology, October 2, 2020. http://dx.doi.org/10.1111/fcp.12603.
Full textBouquet, Emilie, Stéphanie Pain, Céline Eiden, et al. "Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017)." British Journal of Clinical Pharmacology, April 19, 2021. http://dx.doi.org/10.1111/bcp.14812.
Full textBouquet, Emilie, Céline Eiden, Bernard Fauconneau, et al. "Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020." Scientific Reports 12, no. 1 (2022). http://dx.doi.org/10.1038/s41598-022-19197-2.
Full textRoussin, Anne, Thomas Soeiro, Charlotte Fouque, et al. "Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data." British Journal of Clinical Pharmacology, April 5, 2022. http://dx.doi.org/10.1111/bcp.15323.
Full textGandolfo, Pauline, Thomas Soeiro, Élisabeth Jouve, et al. "Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network." Fundamental & Clinical Pharmacology, February 19, 2024. http://dx.doi.org/10.1111/fcp.12995.
Full text